190 related articles for article (PubMed ID: 30583601)
1. Effect of Shape on Mesoporous Silica Nanoparticles for Oral Delivery of Indomethacin.
Zhang W; Zheng N; Chen L; Xie L; Cui M; Li S; Xu L
Pharmaceutics; 2018 Dec; 11(1):. PubMed ID: 30583601
[TBL] [Abstract][Full Text] [Related]
2. Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs.
Gou K; Wang Y; Guo X; Wang Y; Bian Y; Zhao H; Guo Y; Pang Y; Xie L; Li S; Li H
Acta Biomater; 2021 Oct; 134():576-592. PubMed ID: 34280558
[TBL] [Abstract][Full Text] [Related]
3. Mesoporous silica nanorods for improved oral drug absorption.
Zheng N; Li J; Xu C; Xu L; Li S; Xu L
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1132-1140. PubMed ID: 28783976
[TBL] [Abstract][Full Text] [Related]
4. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
Li T; Geng T; Md A; Banerjee P; Wang B
Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
[TBL] [Abstract][Full Text] [Related]
5. Comparison of bare and amino modified mesoporous silica@poly(ethyleneimine)s xerogel as indomethacin carrier: Superiority of amino modification.
Li J; Xu L; Wang H; Yang B; Liu H; Pan W; Li S
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():710-716. PubMed ID: 26652425
[TBL] [Abstract][Full Text] [Related]
6. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
Xie Z; Gong H; Liu M; Zhu H; Sun H
J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
[TBL] [Abstract][Full Text] [Related]
7. Peptide-laden mesoporous silica nanoparticles with promoted bioactivity and osteo-differentiation ability for bone tissue engineering.
Luo Z; Deng Y; Zhang R; Wang M; Bai Y; Zhao Q; Lyu Y; Wei J; Wei S
Colloids Surf B Biointerfaces; 2015 Jul; 131():73-82. PubMed ID: 25969416
[TBL] [Abstract][Full Text] [Related]
8. Mesoporous silica nanoparticles capped with disulfide-linked PEG gatekeepers for glutathione-mediated controlled release.
Cui Y; Dong H; Cai X; Wang D; Li Y
ACS Appl Mater Interfaces; 2012 Jun; 4(6):3177-83. PubMed ID: 22646097
[TBL] [Abstract][Full Text] [Related]
9. Development of an oral push-pull osmotic pump of fenofibrate-loaded mesoporous silica nanoparticles.
Zhao Z; Wu C; Zhao Y; Hao Y; Liu Y; Zhao W
Int J Nanomedicine; 2015; 10():1691-701. PubMed ID: 25784799
[TBL] [Abstract][Full Text] [Related]
10. Redox-responsive mesoporous silica as carriers for controlled drug delivery: a comparative study based on silica and PEG gatekeepers.
Wang Y; Han N; Zhao Q; Bai L; Li J; Jiang T; Wang S
Eur J Pharm Sci; 2015 May; 72():12-20. PubMed ID: 25701727
[TBL] [Abstract][Full Text] [Related]
11. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan.
Zhang Y; Zhi Z; Jiang T; Zhang J; Wang Z; Wang S
J Control Release; 2010 Aug; 145(3):257-63. PubMed ID: 20450945
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of hollow mesoporous silica microspheres bearing on enhanced oral delivery of curcumin.
Gao Y; Ding S; Huang X; Fan Z; Sun J; Hai Y; Li K
Drug Dev Ind Pharm; 2019 Feb; 45(2):273-281. PubMed ID: 30346852
[TBL] [Abstract][Full Text] [Related]
13. Small molecules modified mesoporous silica nanoparticles orally deliver indomethacin with synergistic effect.
Yin S; Cai L; Li X; Lin K; Shi X; Zhang H; Wang L; Li J
Eur J Pharm Sci; 2024 Apr; 195():106719. PubMed ID: 38309442
[TBL] [Abstract][Full Text] [Related]
14. The On-Off chiral mesoporous silica nanoparticles for delivering achiral drug in chiral environment.
Fan N; Liu R; Ma P; Wang X; Li C; Li J
Colloids Surf B Biointerfaces; 2019 Apr; 176():122-129. PubMed ID: 30597409
[TBL] [Abstract][Full Text] [Related]
15. Superiority of amino-modified chiral mesoporous silica nanoparticles in delivering indometacin.
Li J; Guo Y; Li H; Shang L; Li S
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1085-1094. PubMed ID: 28776393
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous silica nanoparticles as potential carriers for enhanced drug solubility of paclitaxel.
He Y; Liang S; Long M; Xu H
Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():12-17. PubMed ID: 28575958
[TBL] [Abstract][Full Text] [Related]
17. MSNCs and MgO-MSNCs as drug delivery systems to control the adsorption kinetics and release rate of indometacin.
Zheng X; Feng S; Wang X; Shi Z; Mao Y; Zhao Q; Wang S
Asian J Pharm Sci; 2019 May; 14(3):275-286. PubMed ID: 32104458
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Solid Dispersion System Engineered from Mesoporous Silica and Polymers for the Poorly Water Soluble Drug Indomethacin: In Vitro and In Vivo.
Xi Z; Zhang W; Fei Y; Cui M; Xie L; Chen L; Xu L
Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32050600
[TBL] [Abstract][Full Text] [Related]
19. Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets.
Zhao Z; Gao Y; Wu C; Hao Y; Zhao Y; Xu J
Drug Dev Ind Pharm; 2016; 42(2):199-208. PubMed ID: 26114553
[TBL] [Abstract][Full Text] [Related]
20. Construction and characterization of a temperature-responsive nanocarrier for imidacloprid based on mesoporous silica nanoparticles.
Yao P; Zou A; Tian Z; Meng W; Fang X; Wu T; Cheng J
Colloids Surf B Biointerfaces; 2021 Feb; 198():111464. PubMed ID: 33296822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
